Hussein Ghamlouch

788 total citations
27 papers, 341 citations indexed

About

Hussein Ghamlouch is a scholar working on Immunology, Genetics and Hematology. According to data from OpenAlex, Hussein Ghamlouch has authored 27 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 9 papers in Genetics and 9 papers in Hematology. Recurrent topics in Hussein Ghamlouch's work include Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (8 papers) and Multiple Myeloma Research and Treatments (7 papers). Hussein Ghamlouch is often cited by papers focused on Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (8 papers) and Multiple Myeloma Research and Treatments (7 papers). Hussein Ghamlouch collaborates with scholars based in France, United States and United Kingdom. Hussein Ghamlouch's co-authors include Jean‐Pierre Marolleau, Brigitte Gubler, Olivier Bernard, Hakim Ouled‐Haddou, Bruno Royer, Saïd Aoufouchi, Florence Nguyen‐Khac, Gandhi Damaj, Xiaowen Chen and Ari Melnick and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

Hussein Ghamlouch

26 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hussein Ghamlouch France 11 154 136 112 88 79 27 341
Antonella Russo Rossi Italy 12 92 0.6× 129 0.9× 140 1.3× 59 0.7× 151 1.9× 23 384
Ana Inés Landoni Uruguay 10 198 1.3× 123 0.9× 131 1.2× 77 0.9× 29 0.4× 17 334
Xiongpeng Zhu China 9 207 1.3× 48 0.4× 66 0.6× 47 0.5× 128 1.6× 24 345
Toshie Ogasawara Japan 8 114 0.7× 47 0.3× 59 0.5× 46 0.5× 128 1.6× 25 280
Jodie Ulaszek United States 6 154 1.0× 66 0.5× 47 0.4× 26 0.3× 106 1.3× 9 329
Ivan Sloma France 12 104 0.7× 169 1.2× 127 1.1× 15 0.2× 221 2.8× 30 423
Paula de Melo Campos Brazil 11 147 1.0× 101 0.7× 83 0.7× 17 0.2× 168 2.1× 43 353
Véronique Della-Valle France 7 170 1.1× 56 0.4× 90 0.8× 45 0.5× 162 2.1× 11 362
Kadriye Nehir Cosgun United States 6 185 1.2× 172 1.3× 54 0.5× 16 0.2× 157 2.0× 19 413
Jan Molinský Czechia 7 113 0.7× 26 0.2× 55 0.5× 66 0.8× 30 0.4× 17 200

Countries citing papers authored by Hussein Ghamlouch

Since Specialization
Citations

This map shows the geographic impact of Hussein Ghamlouch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hussein Ghamlouch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hussein Ghamlouch more than expected).

Fields of papers citing papers by Hussein Ghamlouch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hussein Ghamlouch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hussein Ghamlouch. The network helps show where Hussein Ghamlouch may publish in the future.

Co-authorship network of co-authors of Hussein Ghamlouch

This figure shows the co-authorship network connecting the top 25 collaborators of Hussein Ghamlouch. A scholar is included among the top collaborators of Hussein Ghamlouch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hussein Ghamlouch. Hussein Ghamlouch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghamlouch, Hussein, Patrick Blaney, Eileen M. Boyle, et al.. (2025). A proinflammatory response and polarized differentiation of stromal elements characterizes the murine myeloma bone marrow niche. Experimental Hematology and Oncology. 14(1). 22–22. 1 indexed citations
2.
Ghamlouch, Hussein, et al.. (2024). Bone Marrow Fibroblasts at the Single-Cell Resolution Level in Multiple Myeloma. Blood. 144(Supplement 1). 4636–4636. 1 indexed citations
3.
4.
Rigo, Riccardo, Rabie Chelbi, Julie Agopian, et al.. (2022). TET2 regulates immune tolerance in chronically activated mast cells. JCI Insight. 7(7). 6 indexed citations
5.
Boyle, Eileen M., Patrick Blaney, Yubao Wang, et al.. (2021). Unifying the Definition of High-Risk in Multiple Myeloma. Blood. 138(Supplement 1). 2714–2714.
6.
Maura, Francesco, Eileen M. Boyle, Even H Rustad, et al.. (2021). Chromothripsis as a pathogenic driver of multiple myeloma. Seminars in Cell and Developmental Biology. 123. 115–123. 25 indexed citations
7.
Ghamlouch, Hussein, Eileen M. Boyle, Patrick Blaney, et al.. (2021). Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancer. Journal of Experimental & Clinical Cancer Research. 40(1). 380–380. 8 indexed citations
8.
9.
Roos‐Weil, Damien, Brian Giacopelli, Marine Armand, et al.. (2020). Identification of two DNA methylation subtypes of Waldenström's macroglobulinemia with plasma and memory B cell features. Blood. 136(5). 585–595. 6 indexed citations
10.
Della-Valle, Véronique, Damien Roos‐Weil, Laurianne Scourzic, et al.. (2020). Nfkbie-deficiency leads to increased susceptibility to develop B-cell lymphoproliferative disorders in aged mice. Blood Cancer Journal. 10(3). 38–38. 10 indexed citations
11.
Gomila, Cathy, Hakim Ouled‐Haddou, Pierre Morel, et al.. (2020). Ascorbic acid (vitamin C) synergistically enhances the therapeutic effect of targeted therapy in chronic lymphocytic leukemia. Journal of Experimental & Clinical Cancer Research. 39(1). 228–228. 19 indexed citations
12.
Rosikiewicz, Wojciech, Xiaowen Chen, Pilar M. Domínguez, et al.. (2020). TET2 deficiency reprograms the germinal center B cell epigenome and silences genes linked to lymphomagenesis. Science Advances. 6(25). eaay5872–eaay5872. 34 indexed citations
13.
Gubler, Brigitte, et al.. (2018). Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective. Frontiers in Immunology. 9. 683–683. 37 indexed citations
14.
Selimoglu‐Buet, Dorothée, Julie Rivière, Hussein Ghamlouch, et al.. (2018). A miR-150/TET3 pathway regulates the generation of mouse and human non-classical monocyte subset. Nature Communications. 9(1). 5455–5455. 28 indexed citations
15.
16.
Delanaud, Stéphane, Sébastien Dupont, Hussein Ghamlouch, et al.. (2016). Impact of prenatal and postnatal exposure to the pesticide chlorpyrifos on the contraction of rat ileal muscle strips: involvement of an inducible nitric oxide synthase‐dependent pathway. Neurogastroenterology & Motility. 29(2). 11 indexed citations
17.
Ghamlouch, Hussein, Hakim Ouled‐Haddou, Jean-Claude Régnier, et al.. (2014). TLR9 Ligand (CpG Oligodeoxynucleotide) Induces CLL B-Cells to Differentiate into CD20+ Antibody-Secreting Cells. Frontiers in Immunology. 5. 292–292. 15 indexed citations
18.
Ghamlouch, Hussein, Hakim Ouled‐Haddou, Gandhi Damaj, et al.. (2013). A Combination of Cytokines Rescues Highly Purified Leukemic CLL B-Cells from Spontaneous Apoptosis In Vitro. PLoS ONE. 8(3). e60370–e60370. 37 indexed citations
19.
Marcq, Ingrid, Rémy Nyga, Hakim Ouled‐Haddou, et al.. (2013). Identification of SLAMF3 (CD229) as an Inhibitor of Hepatocellular Carcinoma Cell Proliferation and Tumour Progression. PLoS ONE. 8(12). e82918–e82918. 19 indexed citations
20.
Caires, Nathalie De Freitas, Sandrine Sarrazin, Florence Depontieu, et al.. (2009). In Vitro Pathways of Vascular Endocan Catabolism and Their Relevance in Sepsis.. A1156–A1156. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonella Russo Rossi Breakdown of academic impact, for papers by Ana Inés Landoni Breakdown of academic impact, for papers by Xiongpeng Zhu Breakdown of academic impact, for papers by Toshie Ogasawara Breakdown of academic impact, for papers by Jodie Ulaszek Breakdown of academic impact, for papers by Ivan Sloma Breakdown of academic impact, for papers by Paula de Melo Campos Breakdown of academic impact, for papers by Véronique Della-Valle Breakdown of academic impact, for papers by Kadriye Nehir Cosgun Breakdown of academic impact, for papers by Jan Molinský
Rankless by CCL
2026